Editorial:WORLD ECHOES JOURNAL AGAINST CLIMATE CHANGE (WEJACC) has Come to Stay

The for free Bi-monthly Journal which shall be distributed Nationally and internationally in GREEN and bold, is a product of WORLD ECHOES MEDIA GROUP published against the backdrop of the increasing need to rally all living forces on board the moving train of global chain actors committed to fighting climate change on all fronts and with all dispositions required.

Time has come under the ladder of mankind with all the trillion problems this planetary village is facing for the press not only in Cameroon but the world to take adequate dispositions to school and educate it’s population on the increasing needs for mobilized efforts or actions to combat climate change.

The immediate therapy or counter offensive to climate change, time has proven that the media is the fastest and the best solvent or solution. Through accelerated media reports, media awareness campaigns, crusades, press conferences and advocacy the people will be awakened and enlightened.

In fact WEJACC is a 21^st century community based media approach to combat climate change through mobilized press report actions that will involve community volunteers, town criers, quarter heads, health personnel’s, chiefs, traditional Council heads, Councilors, politicians, parliamentarians, Senators, basically every body.

The rope to combat climate change has dragged on for long and we of World Echoes MEDIA GROUP have chosen and taken the initiative to cut the rope and bring everybody on board.

Time has come that we will use all necessary media apparatus to transfer, impact and convey the message or  war we are launching against climate change.

To the better understanding of our diverse audiences, we are launching WORLD WAR Four (WW IX) which is A Media war against climate change. The war will last, but with the help of media hopefully, climate change will be crushed.

Our humble appeal with this new product in the market that will circulate to the door steps of every community is that take delight to read the information and articles there in, transmit and apply to impact a life some where and some how.

WEJACC has come with the mission to Unite the Media in Cameroon to Combat climate change that is, “Cameroon Media United to Combat Climate Change”.

Through WEJACC, a network of Cameroon climate change reporters will be formed, Ambassadors against climate change groomed, community based reporters trained.

To make it inclusive WEJACC in collaboration with World Echoes resource and research center together with it’s partners of the Reuters Institute of Journalism, the Oxford Climate Journalism Network at Oxford University and Deutsch Wella news service will organize training seminars and capacity building program to groom young talented climate change reporters including those living with Disabilities.

Going beyond news room reporting, WEJACC will go beyond to tree planting, the promotion of tree planting, waste recycling and proper management, nature protection and the recognition of actors in the field through cash prize Award.

That is why in this maiden Edition, we have started by projecting and recognizing Tubah council who have since set the pace through their selfless services to nature and have contributed enormously to combat climate change through waste management and recycling, above all excessive tree planting.

Going about the above literature, you can name all but the truth is that WORLD ECHOES JOURNAL AGAINST CLIMATE CHANGE has been Given birth to and time for action is now. “it is a war we must all win”.

 

Cameroon Gov't Takes Stock, Three Years after the Grand National Dialogue. PM, Officials Express Satisfaction at the End

Members of the follow-up committee of the implementation of the resolutions of the Major National Dialogue have saluted the gradual return to peace in the North West and South West Regions.

Meeting at the star building, August 4, 2022, to take stalk of the progress made as far as the implementation of the recommendations of the Dialogue are concerned, 3 years after the major National Dialogue, the members all testified that despite all the odds, peace, love and harmony is returning to these regions hit by the crisis for close to six years today.

Chairing the follow-up committee meeting, the Prime minister and head of Government Chief Dr. Joseph Dion Ngute in his address buttressed the various areas in that progress has been made since the holding of the Major national dialogue, highlighting that there are still some pockets of resistance posed by the separatist fighters

On the reopening of schools, Prime minister Dion Ngute, with so much joy in his heart made evidenced by his facial expression announced with great delight that, after the drastic fall in the number of children going to school in these regions at the start of the crisis, which at a certain point went down to 20,000 in 2017 for the South West region but that number today has tripled as the South West Region counts over 91000 children going to school while the North West alone counts 71000 according to statistics of the last academic year and it seems the situation is improving as the years unfold.

The restart of agricultural activities in the regions is gradually improving as fresh-looking vegetables are in the markets of the urban centers of Cameroon from the North West Region.

The Prime minister mentioned they have been a significant revamping of agricultural activities in these regions as more and more people are returning to continue their farming activities that were interrupted due to the crisis. He also highlighted that even the CDC whose activities were grounded at the start of the crisis has picked up steam and has begun exporting its products to Europe and the Americas. To the delight of many, it has greatly improved the living condition of the population of these regions.

Messages of peace and love from former extremists

At the start of the crisis in 2016 hate speech was the order of the day, as brothers and sisters of the same country could not look into the eyes of each other and talk peace but today thanks to the creation of the national commission for the promotion of bilingualism and multiculturalism, whose members have been doing a commendable job by preaching against hate speech. There has been a remarkable transformation as the population now upholds virtues of peace, love, reconciliation, and progress. The population is gradually turning its backs against separatists and enemies of peace.

Decentralization and the special status of the North West and South West

One of the strong recommendations of the major national dialogue was the granting of special status to the North West and South West Regions. Their linguistic, legal, socio-cultural, and educational specificity tabled a need for them to be treated differently from the other 8 regions. The public independent conciliators of these 2 regions have been appointed and are currently carrying out their duties. The house of chiefs which is a particular identity to the people of the North West and South West was put in place during the regional council elections. All these measures were taken to answer the grievances raised by the population of these regions and accommodate them in a country that is one and indivisible.

Despite the great strides, there is still a lot to do

It is true without much doubt the situation in the North West and South West has greatly improved. Schools have reopened, many separatist fighters have dropped their guns, the regions are currently under reconstruction, and love and harmony seem to be flowing down the streams of these regions but there is much that is still to be done. Separatist fighters are still in control of some parts of these regions, arms are still been trafficked, bombings and killings even in the church everywhere seems to be dark, and everywhere seems to still be In slumber. The members of the committee quite aware of these happenings brained stormed on the possible way out with hope, that there is a bright light at the end of the tunnel. They called on the population to be more collaborative with the government so that in the end we will laugh when all will be said and done.

Reactions of other members at the end of the meeting

The 4th session of the follow-up committee of the major national dialogue brought together people of timber and caliber. It was unique this year, as it saw the presence of some members of the diaspora.

Speaking to the press at the end of the meeting Mr. Paddy a very active member of the Cameroonian diaspora on the crisis said "I am very happy that I was invited to this meeting. At least there was a platform for me to air my mind. I told the members during the meeting that let those in the diaspora that has been accused of so many crimes be granted amnesty so that they can freely return to the country and give their own opinion on a possible way out of this crisis. My prayer is that they should be heard and let's all talk as brothers and sisters".

On the question of the special status, Mr. Paddy remarked that "the content of the special status should be clearly defined. I don’t believe in the form but I am interested in the details. I hope this will be looked into’’ he added.

A lot has been done to bring back peace in the 2 English-speaking parts of the country. Maybe what is left now is the sincerity to completely implement the resolutions taken during the dialogue.

The members of the follow-up committee left the meeting with much satisfaction and with hope that, things will keep improving

At the end of 2022 International AIDS Conference, Sharon Lewin Assumes IAS Presidency

IAS – the International AIDS Society – welcomed Sharon Lewin (Australia) as the next IAS President and Beatriz Grinsztejn (Brazil) as President-Elect today. IAS leadership also expressed deep gratitude to Adeeba Kamarulzaman (Malaysia) who steps down as IAS President and assumes her role as immediate-past President.

Lewin, a world-renowned infectious diseases physician and basic scientist, is also the inaugural Director of the Peter Doherty Institute for Infection and Immunity, a joint venture of the University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia. For more on Sharon’s extraordinary work and accomplishments.

Addressing delegates at the closing ceremony of AIDS 2022, the 24th International AIDS Conference, Lewin outlined her vision and explained why she remains an optimist about the strength of the global HIV response.

"AIDS 2022 has made it clear once again: progress happens when we come together and unleash the power of our movement. That is why the IAS exists. That is why we need to double down on our efforts to unite the voices of activists, policy makers and scientists," Lewin said.

"At AIDS 2022, we called on the world to re-engage and follow the science, and I can think of no better leader than Sharon to champion this cause and assume the leadership of the IAS," Kamarulzaman said of her successor. "These past two years, as another pandemic overtook the planet, Sharon’s pioneering HIV cure research and analysis have become even more important, providing a roadmap for the global response to COVID-19."

Similarly, Lewin expressed her admiration for Kamarulzaman and her leadership of the IAS over the past two years. 

"Adeeba has spent decades challenging stigma, dismissing taboos and shattering glass ceilings," Lewin said. "She brought this tenacity to her two-year term, leading the IAS through the uncertainty of the COVID-19 pandemic and a historic era, including our first-ever hybrid conference. As a woman in science, I look forward to the day when two consecutive female presidents isn’t remarkable – but today it is and I’m proud to be a part of this new era."

As Lewin assumes her new role as IAS President, Beatriz Grinsztejn assumes her role of President-Elect. Grinsztejn, an infectious diseases physician, is the Director of the STD/AIDS Clinical Research Laboratory and principal investigator of the FIOCRUZ HIV Prevention and Therapeutic Clinical Trials Unit in Rio de Janeiro.

The IAS also announced newly elected members of its Governing Council, which determines strategy and policy direction for IAS to ensure that the organization fulfils its mission.

NEWS RELEASE II 2022 AIDS Conference Canada, Montreal

Journal of the International AIDS Society publishes special issue on investigation of new HIV drugs in pregnancy

30 July 2022 (Montreal, Canada) – The Journal of the International AIDS Society (JIAS) has launched a special issue, titled “Approaches to enhance and accelerate investigation of new HIV drugs in pregnancy”, at AIDS 2022, the 24th International AIDS Conference.   The content of the special issue has been guided by Guest Editors Elaine J Abrams (ICAP at Columbia University) and Martina Penazzato (World Health Organization). The special issue is funded by the World Health Organization.   As antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) are increasingly scaled up globally, a large number of people receiving antiretrovirals (ARVs) for treatment or prevention are of reproductive age and could become pregnant while on ART. However, therapeutics are rarely investigated in pregnant people, leaving women and their providers to deal with uncertainty around the effectiveness and safety of various medications for themselves and their babies. Multiple agencies and actors have voiced their concerns about the exclusion of pregnant women from clinical trials and the associated harms and risks of these policies. A conceptual shift is required to ensure that pregnant people have equal access to medical innovation in HIV treatment and prevention. The collection of articles in this special issue argues for the need to reframe the current approach: From pregnant women as a vulnerable population to a complex population From protection from research to protection through research From presumptive exclusion to fair inclusion Timely investigation of novel agents requires earlier completion of pre-clinical studies and better support for people who become pregnant during the conducting of studies of new agents and want to continue to receive the study drug. As the articles in this supplement discuss, pharmacokinetics and early safety data should be generated before market authorization, and dedicated studies to fully explore maternal and infant outcomes should be initiated for priority products with anticipated broad use. Taken together, the principles and approaches discussed in this supplement chart a path to enable pregnant and breastfeeding people to be included early in registrational studies. Innovations discussed in the articles have the potential to disrupt the status quo and transform the way we include pregnant people in HIV drug research. Accelerating the introduction of new ARVs for this population and allowing for better regimen harmonization across populations will, in turn, improve ART and PrEP scale-up efforts.   Access the special issue here: https://bit.ly/JIAS_Pregnancy   The Journal of the International AIDS Society (JIAS) is the official peer-reviewed journal of the IAS. Founded in 2004, it is an open-access, PubMed- and Medline-indexed journal. JIAS articles are published online on an article-by-article basis. The journal’s primary purpose is to provide an open-access platform for the generation and dissemination of evidence from a wide range of HIV-related disciplines, encouraging research from low- and middle-income countries. In addition, JIAS aims to strengthen capacity and empower less-experienced researchers from resource-limited countries. For more information, visit www.jiasociety.org.  IAS – the International AIDS Society – convenes, educates and advocates for a world in which HIV no longer presents a threat to public health and individual well-being. After the emergence of HIV and AIDS, concerned scientists created the IAS to bring together experts from across the world and disciplines to promote a concerted HIV response.   Today, the IAS and its members unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all those living with and affected by HIV.   The International AIDS Conference, the IAS Conference on HIV Science and the HIV Research for Prevention Conference.  For more information, visit www.iasociety.org.

Mayor Tanjong Launch Phase II Strategic Development Plan on How to Manage and Recycle Waste in Tubah Municipality

That was in the conference hall of Icham Hotel in Bambili on the 29^th of July 2022 in the Presence of the DO of Tubah Metougue, who represented the SDO of Mezam Emile Moh, the Four Fons of Tubah and the Lamido of Sabga, all service Heads, religious authorities, Councilors and Tubah Council workers.

Phase II of the Tubah Council strategic development program comes against the back drop of the increasing need to beef up hygiene and sanitation in the Municipality as population increase or explode with the student population that is on the rise daily at the University of Bamenda.

Disposing of these garbage of late has and continues to pose as a serious problem and health damage not to talk of pollution which is what pushed the Tubah Council to go on all fronts to mobilize, source for funds and partner with Ministries to  combat.

Friday the 29^th of July 2022 gave the Mayor of Tubah Council Tanjong Martin the singular opportunity to explain and show case what the Council has done since 2013 as a passion to combat refuse, what the Council is doing and what the Council is embarking on seriously to completely sweep dirtiness out of Tubah and Make the Municipality garbage and pungy smell free.

On the occasion, a litany of equipments, heavy duty machines and waste collection, disposal cans, the operation team was presented to the officials and public.

With strict orders and firm instructions on how to go about the mobilization and clean up campaign from each household to the quarter from the offices to the streets and why not the suburbs.

In the program as projected in the conference center, waste recycling and management, tree planting was also a subject matter which the Tubah Council is trashing. At the moment over 50000 trees has been planted by the Tubah Council for the past 9 years and they are running a pavement bricks fabrication company, made out of collected plastic materials and containers.

The Mayor of Tubah speaking to the Press after the three phase occasion, to media men and women observed, that the mission or theme of the strategic action development plan to keep Tubah Clean is “How to Manage Waste in Tubah and Make Our Lives Better” through mobilized efforts and redefine actions and approach to waste management. To end, he exhorted the officials and population of Tubah to accompany the Council in their campaign or mission to keep Tubah Municipality completely and perfectly clean.

The DO of Tubah, Metougue on his part, closing the ceremony, thanked the Mayor for taking such a bold step and for acquiring all the materials in place. Pleading on all present to join hands with the Council to see such an effort come to pass veritably and concretely.

The efforts of the Council, call it engagement or commitment, this Reporter must emphasize is laudable and pace setting to other Mayors all around the Country who are lacking and still to take pains off to join the ban wagon of those promoting hygiene and sanitation through proper waste management, the fight against pollution and nature protection through mass tree planting.

People all Comprised Around the World, Gather Today at Montreal Canada for the 2022 World AIDS Conference

 

This year’s conference, which is to start in some few hours is placed on theme “Re-engage and Follow Science”.

The 24th conference promises to include reports on the latest science and studies on HIV criminalization, pre-exposure prophylaxis (PrEP), coinfections, monkeypox, DoxyPEP, and HIV cure case.

As we report the stage is set as all active participants, delegates and delegations from around the world are all gathered to discuss health and chart millennium development goals that can only be fostered and strengthened with adequate health policies and appropriate solutions to tackle pressing global health issues which begins and ends with AIDS.

Actors and all stake holders at the end of the 4 days conference are expected to carry home messages and knowledge that will contribute to control the rate of infection and sustain lives.

The Media as we report are equally mobilized to that effect. As above a 1000 Media houses around the world have been accredited to cover and filter out on daily bases what participants will be carrying out or arriving at as resolutions at the end of the 24^th AIDS international conference starting today the 29^th of July 2022, to end on the 2^nd of August 2022.

Momentum Builds to Deliver Long-Acting PrEP for HIV PreventionMomentum Builds to Deliver Long-Acting PrEP for HIV Prevention

 

Press Release II 28 JULY 2022 AIDS International Conference Canada 

New research, WHO guidelines, voluntary licensing agreement and global coalition announced at AIDS 2022

 

28 July 2022 (Montreal, Canada) – A series of announcements today ahead of AIDS 2022, the 24th International AIDS Conference – including late-breaking study results, new WHO guidelines, a major voluntary licensing agreement and a new global coalition – built momentum for global access to long-acting cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention.   Oral PrEP was first approved by the US Food and Drug Administration a decade ago, but uptake and adherence have been limited, partly because some people have difficulty taking daily pills. In recent years, studies have shown that CAB-LA, administered by injection once every two months, is a safe and effective alternative to oral PrEP. CAB-LA is approved for PrEP only in the US, but its maker, ViiV Healthcare, has submitted marketing applications in additional countries.   “Long-acting PrEP could play a major role in ending the HIV pandemic, but right now, very few people can get it,” Adeeba Kamarulzaman, President of conference host IAS – the International AIDS Society – and International Co-Chair of AIDS 2022, said. “Scaling up affordable access to this game-changing prevention tool must be a top global priority.”   At today’s press conference, researchers presented new data confirming that CAB-LA is safe and effective for PrEP in trans and cisgender women, WHO released its first guidelines for CAB-LA for PrEP, ViiV Healthcare and the Medicines Patent Pool announced that they have signed a voluntary licensing agreement for patents relating to CAB-LA for PrEP. Finally, WHO, Unitaid, UNAIDS and The Global Fund announced the launch of a global coalition to accelerate access to long-acting PrEP with AVAC as the secretariat. Analysis confirms CAB-LA is highly effective for PrEP in trans women; findings suggest gender-affirming hormonal therapy does not impact CAB concentrations Researchers announced that the first trans-specific analysis of data from the landmark HPTN 083 study confirms that CAB-LA is a safe and highly effective HIV prevention option for trans women. HPTN 083 is a Phase 3 study comparing CAB-LA to daily oral TDF/FTC for HIV prevention in cisgender men and trans women who have sex with men. In 2020, researchers announced that HPTN 083 had demonstrated a 66% reduced risk of HIV acquisition for CAB-LA compared to TDF/FTC. The new analysis, which will be presented at AIDS 2022 by Beatriz Grinsztejn of the Evandro Chagas National Institute of Infectious Diseases – Fiocruz (Brazil), reports on the safety, prevention efficacy and pharmacokinetics of CAB-LA in trans women during the blinded phase of HPTN 083. Of 4,566 study participants, 570 (12.5%) were trans women, 330 (57.9%) of whom reported use of gender-affirming hormonal therapy. HIV incidence among trans women was lower in the CAB-LA group (0.54%) than in the TDF/FTC group (1.80%). CAB-LA was well tolerated in trans women and, importantly, initial findings suggest there is no impact of gender-affirming hormonal therapy on CAB concentrations. [Summary is based on abstract; final data presented at the conference may change.] CAB-LA continues to be superior to TDF/FTC for PrEP in cisgender women New data from the HPTN 084 study shows that among individuals assigned female at birth, CAB-LA continues to be superior to daily oral TDF/FTC in preventing HIV infection. HPTN 084 is an ongoing Phase 3 randomized controlled trial of CAB-LA for PrEP in individuals assigned female at birth. In late 2020, a planned interim review found that CAB-LA was superior to daily oral TDF/FTC for HIV prevention in this population. The blinded portion of the trial was then stopped; participants were subsequently unblinded and continued on their original randomized study regimen pending a protocol amendment to offer open-label CAB-LA. This update, to be presented at AIDS 2022 by Sinead Delany-Moretlwe of the University of the Witwatersrand (South Africa), reports that 23 incident infections (3 CAB-LA, 20 TDF/FTC) were detected in the 12-month unblinded period. Of these, two (1 CAB-LA, 1 TDF/FTC) occurred during the blinded phase, and only one of the CAB-LA cases had ever received an injection. Cumulatively, 62 incident HIV infections (6 CAB, 56 TDF/FTC) have been observed over 6,626 person-years of follow up (HIV incidence 0.94%). In addition, no new safety concerns were identified. [Summary is based on abstract; final data presented at the conference may change.] [For more information, see the HPTN 084 news release] New WHO guidelines recommend CAB-LA for HIV prevention Also at today’s press conference, WHO released new guidelines for the use of CAB-LA as PrEP for HIV and called for countries to consider this safe and highly effective prevention option for people at substantial risk of HIV infection. The guidelines will support countries as they plan for CAB-LA introduction and facilitate urgently needed operational research. [See press release from WHO for additional information] “Long-acting cabotegravir is a safe and highly effective HIV prevention tool, but isn’t yet available outside study settings,” Meg Doherty, Director of WHO’s Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, said. “We hope these new guidelines will help accelerate country efforts to start to plan and deliver CAB-LA alongside other HIV prevention options, including oral PrEP and the dapivirine vaginal ring.” ViiV Healthcare and the Medicines Patent Pool sign voluntary licensing agreement to expand access to CAB-LA for PrEP Also today, ViiV Healthcare and the Medicines Patent Pool (MPP) announced that they have signed a voluntary licensing agreement for patents relating to CAB-LA for HIV PrEP to help enable access in least developed, low-income, lower-middle-income and sub-Saharan African countries. Through this agreement, selected generic manufacturers will have the opportunity to develop, manufacture and supply generic versions of CAB-LA for PrEP in 90 countries, subject to required regulatory approvals. ViiV Healthcare and MPP will now work closely with stakeholders and selected generic manufacturers to enable access to generic CAB-LA for PrEP as soon as possible. “We are delighted to sign this voluntary licence with ViiV for cabotegravir LA for PrEP,” Charles Gore, MPP Executive Director, said. “Long-acting technologies open up a whole new dimension that facilitates medicine uptake, and this product brings a much-needed option for those at risk. This licence was negotiated in double-quick time and is another example of MPP’s continued commitment to making innovation available and affordable in low- and middle-income countries in the shortest possible time. Rapid access to new technologies is our only hope of hitting the Sustainable Development Goal targets.” “Today’s announcement represents a potentially game-changing moment in HIV prevention,” Deborah Waterhouse, CEO at ViiV Healthcare, said. “Enabling at-scale access to generic cabotegravir LA for PrEP could play a significant role in averting the transmission of HIV, particularly amongst women and adolescent girls, and help end the HIV epidemic. I am proud that through our long-standing partnership with MPP, we continue to play our part in widening access for people in resource-limited countries to new innovative medicines.” [See press release from Medicines Patent Pool here] Global coalition launched to accelerate access to long-acting PrEP Today also marked the launch of the new Coalition to Accelerate Access to Long-Acting PrEP. Convened by WHO, Unitaid, UNAIDS and The Global Fund, and with AVAC as the secretariat, the coalition will coordinate key stakeholder activities on PrEP access, including jointly developing strategies to identify and overcome access challenges for new PrEP options in the near to medium term (especially related to ViiV’s injectable CAB, including generics) and the medium to longer term (related to future PrEP products). “New HIV prevention options now reaching the market, such as injectable cabotegravir, hold the promise to transform HIV prevention,” Tenu Avafia, Deputy Executive Director of Unitaid, said. “But we must move far more quickly than we did with oral PrEP if we are to have real impact on the epidemic. This new coalition being formed will prioritize the acceleration of affordable, equitable and widespread access to injectable long-acting cabotegravir for PrEP without delay. Community response "Afrocab and our community partners are excited about today’s announcement,” Jacque Wambui, Global CAB facilitator at Afrocab, said. “Since we began mobilizing community partners around the world almost six months ago, we have been encouraged to see the responsiveness and engagement from global partners that have made this announcement possible. "However, we recognize this is just the first step on this path for long-acting cabotegravir for PrEP. Speedy technology transfer and low-cost pricing have still not been secured. Until then, the promise of accessible, affordable CAB-LA will not be realized. Afrocab and our community partners will continue to advocate around these issues until they are resolved."

IAC – the International AIDS Conference – is the premier global platform to advance the HIV response. As the world’s largest conference on HIV and AIDS, it sits uniquely at the intersection of science, advocacy and human rights, bringing together scientists, policy makers, healthcare professionals, people living with HIV, funders, media and community. Since its start in 1985, the conference continues to serve as an opportunity to strengthen policies and programmes that ensure an evidence-based response to HIV and related epidemics.

The 24th International AIDS Conference – known as AIDS 2022 – will be hosted in Montreal, Canada, and virtually from 29 July to 2 August 2022.

For more information, visit www.aids2022.org. 

IAS – the International AIDS Society – convenes, educates and advocates for a world in which HIV no longer presents a threat to public health and individual well-being. After the emergence of HIV and AIDS, concerned scientists created the IAS to bring together experts from across the world and disciplines to promote a concerted HIV response

Today, the IAS and its members unite scientists, policy makers and activists to galvanize the scientific response, build global solidarity and enhance human dignity for all those living with and affected by HIV.

The IAS also hosts the world’s most prestigious HIV conferences: the International AIDS Conference, the IAS Conference on HIV Science and the HIV Research for Prevention Conference. 

For more information, visit www.iasociety.org.